Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
- PMID: 26347515
- PMCID: PMC4849697
- DOI: 10.5009/gnl15021
Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
Erratum in
-
Erratum: Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.Gut Liver. 2016 Jul 15;10(4):653-655. doi: 10.5009/gnl150211. Gut Liver. 2016. PMID: 27377743 Free PMC article. No abstract available.
Abstract
Background/aims: Few studies have investigated prognostic factors for the development of liver-related events (LREs) in patients with chronic hepatitis C (CHC) who achieve sustained virological response (SVR).
Methods: We analyzed 190 patients with CHC who achieved SVR after treatment with pegylated interferon (peg-IFN) plus ribavirin. LREs were defined as any complications related to cirrhosis, hepatocellular carcinoma (HCC), or liver-related mortality.
Results: The mean age was 54.1 years, and 84 of the patients (44.2%) were male. The mean liver stiffness (LS) value at SVR was 7.1±5.4 kPa. During the follow-up period (median, 43.0 months), LREs occurred in 10 patients (5.3%; HCC in eight patients, ascites in one patient, and liver-related mortality in one patient). By multivariate Cox regression analysis, age, α-fetoprotein level, and LS value were independent predictors for LRE development (all p<0.05). Patients with LS values ≥7.0 kPa had a greater risk (hazard ratio, 9.472; 95% confidence interval, 1.018 to 88.126; p=0.048) for LRE development compared to those with LS values <7.0 kPa.
Conclusions: The LS value at SVR is useful for predicting LRE development in CHC patients who achieve SVR after treatment with peg-IFN plus ribavirin. Thus, LRE surveillance strategies might be optimized according to the LS values at SVR, even with complete viral eradication.
Keywords: Carcinoma, hepatocellular; Hepatitis C, chronic; Liver stiffness; Sustained virological response; Transient elastography.
Figures



Similar articles
-
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.J Gastroenterol Hepatol. 2007 May;22(5):669-75. doi: 10.1111/j.1440-1746.2007.04898.x. J Gastroenterol Hepatol. 2007. PMID: 17444854
-
Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.Antivir Ther. 2011;16(7):959-68. doi: 10.3851/IMP1842. Antivir Ther. 2011. PMID: 22024511
-
Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1223-1230. doi: 10.1097/MEG.0000000000000964. Eur J Gastroenterol Hepatol. 2017. PMID: 28857900
-
Treatment of chronic hepatitis C in southern Taiwan.Intervirology. 2006;49(1-2):99-106. doi: 10.1159/000087271. Intervirology. 2006. PMID: 16166797 Review.
-
Long-term effects of interferon-based therapy for chronic hepatitis C.Oncology. 2007;72 Suppl 1:16-23. doi: 10.1159/000111703. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087178 Review.
Cited by
-
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.Cancers (Basel). 2021 Sep 11;13(18):4567. doi: 10.3390/cancers13184567. Cancers (Basel). 2021. PMID: 34572795 Free PMC article.
-
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.Curr Opin Virol. 2016 Oct;20:99-105. doi: 10.1016/j.coviro.2016.09.010. Epub 2016 Oct 11. Curr Opin Virol. 2016. PMID: 27741441 Free PMC article. Review.
-
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment.BMC Gastroenterol. 2023 Apr 3;23(1):102. doi: 10.1186/s12876-023-02732-4. BMC Gastroenterol. 2023. PMID: 37013471 Free PMC article.
-
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study.Clin Mol Hepatol. 2021 Jan;27(1):125-135. doi: 10.3350/cmh.2020.0023. Epub 2020 Nov 27. Clin Mol Hepatol. 2021. PMID: 33242929 Free PMC article.
-
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.Clin Mol Hepatol. 2024 Sep;30(Suppl):S5-S105. doi: 10.3350/cmh.2024.0506. Epub 2024 Aug 19. Clin Mol Hepatol. 2024. PMID: 39159947 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources